匹多莫德与童康片联合治疗小儿反复呼吸道感染的临床效果观察

Clinical observation of pidomorph combined with tongkang tablet in the treatment of children with recurrent respiratory tract infection

目的分析匹多莫德与童康片联合治疗小儿反复呼吸道感染的临床效果。方法回顾性分析我院收治的72例反复呼吸道感染患儿的临床资料,根据治疗方法将其分为研究组(36例)与对照组(36例)。对照组患儿给予匹多莫德治疗,研究组患儿给予匹多莫德与童康片联合治疗,对比两组患儿的治疗总有效率与血清免疫球蛋白水平。结果与对照组相比,研究组36例反复呼吸道感染患儿的治疗总有效率明显更高,差异有统计学意义(P<0.05);治疗后,研究组患儿的IgG、IgA水平明显优于对照组患儿,差异有统计学意义(P<0.05)。结论匹多莫德与童康片联合治疗小儿反复呼吸道感染,临床效果十分显著,值得在临床治疗工作中推广运用。

Objective To analyze the clinical effect of pidotamine combined with tongkang tablet in the treatment of children with recurrent respiratory tract infection. Methods Seventy-two cases of children with recurrent respiratory tract infection in our hospital were retrospectively analyzed. They were divided into study group （36 cases） and control group （36 cases） according to treatment method. The control group was given pidomorph treatment, while the study group was given pidotamine combined with tongkang tablets. The total effective rate and serum immunoglobulin levels of the two groups were compared. Results Compared with the control group, the total effective rate of the study group was significantly higher than that of the control group, the difference was statistically significant （P〈0.05）. After treatment, the levels of IgG and IgA in the study group were significantly better than those in the control group, the differences were statistically significant （P〈0.05）. Conclusion The clinical effect of pidotimer and tongkang tablet in the treatment of children with recurrent respiratory tract infection is very significant, it is worth to be popularized in clinic.